These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31328452)

  • 21. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
    Kalff V; Duong C; Drummond EG; Matthews JP; Hicks RJ
    J Nucl Med; 2006 Jan; 47(1):14-22. PubMed ID: 16391182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (
    Scher N; Castelli J; Depeursinge A; Bourhis J; Prior JO; Herrera FG; Ozsahin M
    Cancer Radiother; 2018 May; 22(3):229-235. PubMed ID: 29650390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.
    Kidd EA; Siegel BA; Dehdashti F; Rader JS; Mutch DG; Powell MA; Grigsby PW
    J Clin Oncol; 2010 Apr; 28(12):2108-13. PubMed ID: 20308664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer.
    Chung HH; Kim JW; Han KH; Eo JS; Kang KW; Park NH; Song YS; Chung JK; Kang SB
    Gynecol Oncol; 2011 Feb; 120(2):270-4. PubMed ID: 21109300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of intracavitary brachytherapy technique (2D versus 3D) on outcomes of cervical cancer: a systematic review and meta-analysis.
    Kim YJ; Kang HC; Kim YS
    Strahlenther Onkol; 2020 Nov; 196(11):973-982. PubMed ID: 32632466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
    Lee HJ; Lee JJ; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
    J Gynecol Oncol; 2017 Jul; 28(4):e43. PubMed ID: 28541634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer.
    Siva S; Herschtal A; Thomas JM; Bernshaw DM; Gill S; Hicks RJ; Narayan K
    Cancer; 2011 Sep; 117(17):3981-8. PubMed ID: 21365626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Value of Volumetric Parameters of Pretreatment 18F-FDG PET/CT in Esophageal Cancer: A Systematic Review and Meta-analysis.
    Han S; Kim YJ; Woo S; Suh CH; Lee JJ
    Clin Nucl Med; 2018 Dec; 43(12):887-894. PubMed ID: 30300200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma.
    Tan AC; Emmett L; Lo S; Liu V; Kapoor R; Carlino MS; Guminski AD; Long GV; Menzies AM
    Ann Oncol; 2018 Oct; 29(10):2115-2120. PubMed ID: 30137228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Textural features of cervical cancers on FDG-PET/CT associate with survival and local relapse in patients treated with definitive chemoradiotherapy.
    Chen SW; Shen WC; Hsieh TC; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yen KY; Kao CH
    Sci Rep; 2018 Aug; 8(1):11859. PubMed ID: 30089896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer.
    Kidd EA; Siegel BA; Dehdashti F; Rader JS; Mutic S; Mutch DG; Powell MA; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1085-91. PubMed ID: 19880262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre- and post-treatment FDG PET-CT as a predictor of patient outcomes in anal squamous cell carcinoma: A systematic review and meta-analysis.
    Mac Curtain BM; Qian W; Bell J; O'Mahony A; Temperly HC; Ng ZQ
    J Med Imaging Radiat Oncol; 2023 Sep; 67(6):634-646. PubMed ID: 37573606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study.
    Sachpekidis C; Larribere L; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A; Hassel JC
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):386-96. PubMed ID: 25359635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of volume-based metabolic parameters of
    Han S; Kim H; Kim YJ; Suh CH; Woo S
    Ann Nucl Med; 2018 Dec; 32(10):669-677. PubMed ID: 30101392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic response of lymph nodes immediately after RT is related with survival outcome of patients with pelvic node-positive cervical cancer using consecutive [18F]fluorodeoxyglucose-positron emission tomography/computed tomography.
    Yoon MS; Ahn SJ; Nah BS; Chung WK; Song HC; Yoo SW; Song JY; Jeong JU; Nam TK
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e491-7. PubMed ID: 22818418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
    Chung HH; Kang SY; Ha S; Kim JW; Park NH; Song YS; Cheon GJ
    J Gynecol Oncol; 2016 Mar; 27(2):e15. PubMed ID: 26768781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer.
    Schwarz JK; Lin LL; Siegel BA; Miller TR; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1502-7. PubMed ID: 18538498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 15-Year Experience of 18F-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell Carcinoma.
    Byrne K; Siva S; Chait L; Callahan J; Bressel M; Seel M; MacManus MP; Hicks RJ
    J Nucl Med; 2015 Sep; 56(9):1328-33. PubMed ID: 26159592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective evaluation of qualitative and quantitative ¹⁸F-FDG PET-CT parameters for predicting survival in recurrent carcinoma of the cervix.
    Maharjan S; Sharma P; Patel CD; Sharma DN; Dhull VS; Jain SK; Thulkar S; Malhotra A; Kumar R
    Nucl Med Commun; 2013 Aug; 34(8):741-8. PubMed ID: 23676840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
    Skougaard K; Nielsen D; Jensen BV; Hendel HW
    J Nucl Med; 2013 Jul; 54(7):1026-31. PubMed ID: 23572497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.